Brand Promotion: Mankind’s OTC brand KABZEND
Mankind Pharma, a quality-driven pharmaceutical company in India, has launched a new over-the-counter (OTC) product – KABZEND Natural Laxative Granules to help... Read More
Case Study on USFDA Label Expansion: Novartis’ Kisqali
FDA had approved Kisqali in tandem with an aromatase inhibitor as an initial endocrine-based treatment for pre, peri- or postmenopausal women with... Read More
DRL launches generic Nexium 24HR capsules in US market
Dr Reddy’s Laboratories Ltd. announced the launch of the US Food and Drug Administration (FDA) approved esomeprazole magnesium delayed-release capsules USP, 20... Read More
Geisinger, AstraZeneca partner to create new asthma app suite
Geisinger, an integrated health services organization, and AstraZeneca have partnered to improve asthma care by creating a suite of products that integrate... Read More
Case Study: Global Recall of Valsartan due to it’s impurity that is carcinogenic
Molecule: Valsartan Category: CVS drug Indication: used to treat high blood pressure and heart failure Present status: Valsartan was originally developed by Novartis... Read More
Case Study: Merck’s Health Awareness Initiative with launch of fertility.com
Posted on14 Jul 2018
Comments0
Merck, a leading science and technology company, today announces the launch of the new online portal fertility.com. Fertility.com is the entrance... Read More
Amgen & UCB ‘s Romosozumab: Development Pathway and approval status
Amgen and UCB, a global biopharmaceutical company, announced the resubmission of the Biologics License Application (BLA) to the US Food and Drug... Read More
Case study – Alcon – Novartis Spin-Off: Alcon to become standalone Trading Company
Posted on04 Jul 2018
Comments0
Novartis AG intends to spinoff its ophthalmology division, Alcon, into a separately-traded standalone company. Preset: Novartis acquired Alcon in 2011. The Alcon... Read More
Alcon Cares Project 100 commits to reducing cataract blindness globally
Alcon, the global leader in eye care and a division of Novartis, has announced Alcon Cares Project 100, which aims to reduce... Read More
Licensing Deal: Hikma Pharma launches Basilea’s antibiotic Zevtera in Saudi Arabia
Basilea Pharmaceutica Ltd. announced that its partner Hikma Pharmaceuticals LLC has launched Basilea’s hospital antibiotic Zevtera (ceftobiprole) in Saudi Arabia in first... Read More